Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 65Kidney Neoplasms 18Neoplasms 16Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Colorectal Neoplasms 8Carcinoma, Hepatocellular 8Carcinoma 8Melanoma 7Glioblastoma 5Clear-cell metastatic renal cell carcinoma 5Lung Neoplasms 4Uterine Cervical Neoplasms 3Recurrence 3Ovarian Neoplasms 3Endometrial Neoplasms 3Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Skin Neoplasms 2Sarcoma 2Pheochromocytoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Paraganglioma 2Liver Neoplasms 2Kidney Diseases 2Carcinoma, Adenoid Cystic 2Breast Neoplasms 2Advanced Solid Tumors 2

Interventions

Sorafenib 5Blood Specimen Collection 4lenvatinib 3sintilimab 2pembrolizumab 2ledipasvir, sofosbuvir drug combination 2halofantrine 2camrelizumab 2atezolizumab 2Liver Transplantation 2Immunotherapy 2Control Groups 2Bevacizumab 2Antibodies 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1rubitecan 1repotrectinib 1pevonedistat 1ozanimod 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × Axitinib × Clear all
NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Pfizer

Phase 1 Completed
22 enrolled 25 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡